1)Mariette C, Piessen G, Briez N, et al:Oesophagogastric junction adenocarcinoma:which therapeutic approach? Lancet Oncol 12:296-305, 2011
2)Fujitani K, Miyashiro I, Mikata S, et al:Pattern of abdominal nodal spread and optimal abdominal lymphadenectomy for advanced Siewert type Ⅱ adenocarcinoma of the cardia:results of a multicenter study. Gastric Cancer 16:301-308, 2013
3)Yoshikawa T, Takeuchi H, Hasegawa S, et al:Theoretical therapeutic impact of lymph node dissection on adenocarcinoma and squamous cell carcinoma of the esophagogastric junction. Gastric Cancer 19:143-149, 2016
4)Yamashita H, Seto Y, Sano T, et al:Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma. Gastric Cancer 20(Suppl 1):69-83, 2017
5)Kurokawa Y, Takeuchi H, Doki Y, et al:Mapping of lymph node metastasis from esophagogastric junction tumors:a prospective nationwide multicenter study. Ann Surg 274:120-127, 2021
6)日本胃癌学会(編);胃癌治療ガイドライン医師用2021年7月改訂第6版.金原出版,2021
7)Mine S, Kurokawa Y, Takeuchi H, et al:Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type Ⅱ tumors. Eur J Surg Oncol 41:1348-1353, 2015
8)Kurokawa Y, Sasako M, Sano T, et al:Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia. Br J Surg 102:341-348, 2015
9)Kurokawa Y, Hiki N, Yoshikawa T, et al:Mediastinal lymph node metastasis and recurrence in adenocarcinoma of the esophagogastric junction. Surgery 157:551-555, 2015